Gildea John J, Israel Jonathan A, Johnson Andrew K, Zhang Jin, Jose Pedro A, Felder Robin A
Department of Pathology, University of Virginia Health System, Charlottesville, VA 22908, USA.
Hypertension. 2009 Nov;54(5):1070-6. doi: 10.1161/HYPERTENSIONAHA.109.134338. Epub 2009 Sep 14.
In moderate sodium-replete states, dopamine 1-like receptors (D1R/D5R) are responsible for regulating >50% of renal sodium excretion. This is partly mediated by internalization and inactivation of NaKATPase, when associated with adapter protein 2. We used dopaminergic stimulation via fenoldopam (D1-like receptor agonist) to study the interaction among D1-like receptors, caveolin-1 (CAV1), and the G protein-coupled receptor kinase type 4 in cultured human renal proximal tubule cells (RPTCs). We compared 2 groups of RPTCs, 1 of cell lines that were isolated from normal subjects (nRPTCs) and a second group of cell lines that have D1-like receptors that are uncoupled (uncoupled RPTCs) from adenylyl cyclase second messengers. In nRPTCs, fenoldopam increased the plasma membrane expression of D1R (10.0-fold) and CAV1 (1.3-fold) and markedly decreased G protein-coupled receptor kinase type 4 by 94+/-8%; no effects were seen in uncoupled RPTCs. Fenoldopam also increased the association of adapter protein 2 and NaKATPase by 53+/-9% in nRPTCs but not in uncoupled RPTCs. When CAV1 expression was reduced by 86.0+/-8.5% using small interfering RNA, restimulation of the D1-like receptors with fenoldopam in nRPTCs resulted in only a 7+/-9% increase in association between adapter protein 2 and NaKATPase. Basal CAV1 expression and association with G protein-coupled receptor kinase type 4 was decreased in uncoupled RPTCs (58+/-5% decrease in association) relative to nRPTCs. We conclude that the scaffolding protein CAV1 is necessary for the association of D1-like receptors with G protein-coupled receptor kinase type 4 and the adapter protein 2-associated reduction in plasma membrane NaKATPase.
在适度钠充足状态下,多巴胺1样受体(D1R/D5R)负责调节超过50%的肾钠排泄。这部分是通过钠钾ATP酶的内化和失活介导的,当与衔接蛋白2相关时。我们使用非诺多泮(一种D1样受体激动剂)进行多巴胺能刺激,以研究培养的人肾近端小管细胞(RPTCs)中D1样受体、小窝蛋白-1(CAV1)和4型G蛋白偶联受体激酶之间的相互作用。我们比较了两组RPTCs,一组是从正常受试者分离的细胞系(nRPTCs),另一组是D1样受体与腺苷酸环化酶第二信使解偶联的细胞系(解偶联RPTCs)。在nRPTCs中,非诺多泮使D1R的质膜表达增加了10.0倍,CAV1增加了1.3倍,并使4型G蛋白偶联受体激酶显著降低了94±8%;在解偶联RPTCs中未观察到影响。非诺多泮还使nRPTCs中衔接蛋白2与钠钾ATP酶的结合增加了53±9%,但在解偶联RPTCs中未增加。当使用小干扰RNA使CAV1表达降低86.0±8.5%时,在nRPTCs中用非诺多泮重新刺激D1样受体,导致衔接蛋白2与钠钾ATP酶之间的结合仅增加7±9%。相对于nRPTCs,解偶联RPTCs中的基础CAV1表达以及与4型G蛋白偶联受体激酶的结合减少(结合减少58±5%)。我们得出结论,支架蛋白CAV1对于D1样受体与4型G蛋白偶联受体激酶的结合以及衔接蛋白2相关的质膜钠钾ATP酶减少是必需的。